Report an error

Spotted something inaccurate in “Romiplostim Enables 84% of Cancer Patients to Maintain Full Chemotherapy Dosing”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.